Their commitment is primarily governed by the mutually inhibitory master regulators retinoic acid-related orphan receptor gamma-t (RORt) (driving the Th17 lineage) and forkhead box P3 (Foxp3) (orchestrating the Treg program), within cytokine milieus that favor either pro-inflammatory (e.g., IL-6, IL-23) or anti-inflammatory (e.g., TGF-, IL-2) outcomes ( Figure 1 )
General symptoms, such as fatigue, respiratory distress, and common allergic reactions, are common
Most compounding-pharmacy guidance favours reconstitution volumes that keep doses in the 0.1 to 0.25 mL range for measurement accuracy
Researchers studying combined-compound protocols often investigate the three blend components together
If the proposed mechanism (gradual synaptic plasticity effects) is right, daily dosing might be needed for sustained effect